Organoid models of high grade serous ovarian cancer: investigating the effect of homologous recombination mutations on genomic stability
Organoid models of high grade serous ovarian cancer: investigating the effect of homologous recombination mutations on genomic stability
批准号:
428817
负责人:
Gibbard Evan
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-12-01 至 2020-12-01
中文摘要
高级别浆液性卵巢癌(HGS)是最常见和致命的卵巢癌,全世界每年有12万人死于这种疾病。最近,一种名为聚ADP核糖聚合酶(PARP)抑制剂的抗癌新药显示,
英文摘要
"High-grade serous ovarian cancer (HGS) is the most common and lethal form of ovarian cancer, with 120,000 people a year dying worldwide from this disease. Recently, new cancer-killing drugs called poly ADP ribose polymerase (PARP) inhibitors have shown p
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling High Grade Serous Ovarian Cancer Using Human Fallopian Tube-Derived Organoids
-
批准号:412262
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2019
-
负责人:Gibbard Evan
-
依托单位:
国内基金
海外基金
Journal of Genetics and Genomics
-
批准号:31224803
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:于昕
-
依托单位: